UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force

Annals of oncology, 2014-08, Vol.25 (8), p.1492-1499

2014

Volltextzugriff (PDF)

Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis

Annals of oncology, 2007-02, Vol.18 (2), p.233-240

Grunberg, S.M.

2007

Volltextzugriff (PDF)

A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy

Annals of oncology, 2014-07, Vol.25 (7), p.1328-1333

2014

Volltextzugriff (PDF)

A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy

Annals of oncology, 2006-09, Vol.17 (9), p.1441-1449

2006

Volltextzugriff (PDF)

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference

Annals of oncology, 2010-05, Vol.21 (suppl-5), p.v232-v243

2010

Volltextzugriff (PDF)

Gender differences in barriers to participation in after-school physical activities and related factors in Australian schoolchildren: A cross-sectional study

Health promotion journal of Australia, 2021-10, Vol.32 (S2), p.139-146

2021

Volltextzugriff (PDF)

Proposal for classifying the acute emetogenicity of cancer chemotherapy

Journal of clinical oncology, 1997-01, Vol.15 (1), p.103-109

1997

Volltextzugriff (PDF)

Randomized, double-blind, dose-ranging trial of the oral neurokinin-1 receptor antagonist casopitant mesylate for the prevention of cisplatin-induced nausea and vomiting

Annals of oncology, 2009-11, Vol.20 (11), p.1867-1873

2009

Volltextzugriff (PDF)

Functional relevance of antiemetic control: experience using the FLIE questionnaire in a randomised study of the NK-1 antagonist aprepitant

European journal of cancer (1990), 2003-07, Vol.39 (10), p.1395-1401

2003

Volltextzugriff (PDF)

Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--an update

Supportive care in cancer, 2005-02, Vol.13 (2), p.80-84

2005

Volltextzugriff (PDF)

Antiemetics: A Window to Translational Medicine

Annals of oncology, 2012-09, Vol.23, p.ix64

Grunberg, S.

2012

Volltextzugriff (PDF)

Role of antiprogestational therapy for meningiomas

Human reproduction (Oxford), 1994-06, Vol.9 (suppl-1), p.202-207

GRUNBERG, S. M

1994

Volltextzugriff (PDF)

Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor Antagonist

The New England journal of medicine, 1999-01, Vol.340 (3), p.190-195

1999

Volltextzugriff (PDF)

Transglutaminases and Transglutaminase-Catalyzed Cross-Links Colocalize with the Pathological Lesions in Alzheimer's Disease Brain

Brain pathology (Zurich, Switzerland), 2009-10, Vol.19 (4), p.612-622

2009

Volltextzugriff (PDF)

Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone

Journal of neurosurgery, 1991-06, Vol.74 (6), p.861-866

1991

Volltextzugriff (PDF)

Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response

Supportive care in cancer, 2006-04, Vol.14 (4), p.354-360

2006

Volltextzugriff (PDF)

Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the lung cancer symptom scale

Cancer, 1994-04, Vol.73 (8), p.2087-2098

1994

Volltextzugriff (PDF)

1572P - Safety and Efficacy of Oral Palonosetron in Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) over Multiple Cycles of Moderately Emetogenic Chemotherapy (MEC)

Annals of oncology, 2012-09, Vol.23, p.ix507-ix507

2012

Volltextzugriff (PDF)

Safety and Efficacy of Oral Palonosetron in Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) over Multiple Cycles of Moderately Emetogenic Chemotherapy (MEC)

Annals of oncology, 2012-09, Vol.23, p.ix507

2012

Volltextzugriff (PDF)

Prevalence of Mouth and Throat Soreness (MTS) in Patients undergoing Lung Cancer Treatment, with Adverse Impact on Functional and Quality of Life Outcomes

International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S680-S680

2008

Volltextzugriff (PDF)

Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group

Journal of clinical oncology, 1993-05, Vol.11 (5), p.873-878

1993

Volltextzugriff (PDF)

Comparison of Conditional Quality of Life Terminology and Visual Analogue Scale Measurements

Quality of life research, 1996-02, Vol.5 (1), p.65-72

1996

Volltextzugriff (PDF)

Efficacy and safety of granisetron, a selective 5-hydroxytryptamine-3 receptor antagonist, in the prevention of nausea and vomiting induced by high-dose cisplatin

Journal of clinical oncology, 1994-10, Vol.12 (10), p.2204-2210

1994

Volltextzugriff (PDF)

Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: Results of a phase III, single-dose trial versus dolasetron

Cancer, 2003-12, Vol.98 (11), p.2473-2482

2003

Volltextzugriff (PDF)

Stage shift and complementary/alternative medicine

Journal of clinical oncology, 2000-10, Vol.18 (19), p.3455-3456

Grunberg, S M

2000

Volltextzugriff (PDF)

1 – 25 von 3.544

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.695)
Mit Volltextzugriff
(2.839)

Publikationsform

7 weitere anzeigen...

Weniger anzeigen...

Sprache

9 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.361)
Life Sciences & Biomedicine
(906)
Humans
(652)
Female
(358)
Biological And Medical Sciences
(331)
Physical Sciences
(324)
Male
(303)
Physics
(298)
Animals
(282)
Adult
(188)
Medical Sciences
(174)
Biochemistry & Molecular Biology
(140)
Aged
(133)
Oncology
(133)
Middle Aged
(113)
Exact Sciences And Technology
(109)
Social Sciences
(105)
Technology
(105)
Chemistry
(90)
Fundamental And Applied Biological Sciences. Psychology
(82)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force

Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis

A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy

A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference

Gender differences in barriers to participation in after-school physical activities and related factors in Australian schoolchildren: A cross-sectional study

Proposal for classifying the acute emetogenicity of cancer chemotherapy

Randomized, double-blind, dose-ranging trial of the oral neurokinin-1 receptor antagonist casopitant mesylate for the prevention of cisplatin-induced nausea and vomiting

Functional relevance of antiemetic control: experience using the FLIE questionnaire in a randomised study of the NK-1 antagonist aprepitant

Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--an update

Antiemetics: A Window to Translational Medicine

Role of antiprogestational therapy for meningiomas

Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor Antagonist

Transglutaminases and Transglutaminase-Catalyzed Cross-Links Colocalize with the Pathological Lesions in Alzheimer's Disease Brain

Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone

Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response

Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the lung cancer symptom scale

1572P - Safety and Efficacy of Oral Palonosetron in Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) over Multiple Cycles of Moderately Emetogenic Chemotherapy (MEC)

Safety and Efficacy of Oral Palonosetron in Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) over Multiple Cycles of Moderately Emetogenic Chemotherapy (MEC)

Prevalence of Mouth and Throat Soreness (MTS) in Patients undergoing Lung Cancer Treatment, with Adverse Impact on Functional and Quality of Life Outcomes

Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group

Comparison of Conditional Quality of Life Terminology and Visual Analogue Scale Measurements

Efficacy and safety of granisetron, a selective 5-hydroxytryptamine-3 receptor antagonist, in the prevention of nausea and vomiting induced by high-dose cisplatin

Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: Results of a phase III, single-dose trial versus dolasetron

Stage shift and complementary/alternative medicine

Suchergebnisse filtern